Clinical trial
TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer
NCT00399750 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00399750 |
|---|---|
| Title | TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer |
| Official title | A Randomized Prospective Study Comparing Three Regimens of Oxaliplatin Plus Fluoropyrimidine and Avastin for Evaluation of Safety and Tolerability in First-line Treatment of Patients With Advanced Colorectal Cancer. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin, fluoropyrimidine, bevacizumab |
| Enrollment | 373 |
| Start date | Nov 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Nov 15, 2006 |
| Last update posted | Oct 15, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: